Dhampur Bio Organics Ltd - 543593 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Deepa Goel Dhampur Bio Organics Ltd - 543593 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Saraswati Properties Ltd Dhampur Bio Organics Ltd - 543593 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Gaurav Goel Dhampur Bio Organics Ltd - 543593 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
In Continuation to our letter dated January 24, 2023 and in compliance with the regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Please find attached the Transcript of Investor Conference Call/ Analyst Meet held on January 24, 2023. Dhampur Bio Organics Ltd - 543593 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
In Compliance with the Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015, we hereby inform that the Audio recording of Analyst Meet/ Investor Conference Call on Unaudited Financial Result for the quarter and nine months ended December 31, 2022, held on January 24, 2023 is available on the website of the Company at https://www.dhampur.com/investor/financials under the head 'Conference call'. Q3FY23 Quarterly Result Announced for Dhampur Bio Organics Ltd.
Sugar firm Dhampur Bio Organics announced Q3FY23 results: Q3FY23: The Revenue of the company increased to Rs 697.08 crore in Q3 FY23 as against Rs 348.00 crore during Q3FY22. PBT stood at Rs 20.18 crore in Q3FY23 as against Rs 24.61 crore during Q3FY22. PAT stood at Rs 14.97 crore in Q3FY23 as against Rs 17.93 crore during Q3FY22. EPS stood at Rs 2.25/share for Q3FY23 as against Rs 2.70/share for Q3FY22. Result PDF Dhampur Bio Organics Ltd - 543593 - Results- Financial Results For The Quarter And Nine Months Ended December 31, 2022
Pursuant to the provisions of the SEBI Listing Regulations, we wish to inform you that, the Board of Directors at its Meeting held today i.e. January 23, 2023, has inter-alia approved the following: i) Unaudited (Standalone and Consolidated) Financial Results for the quarter and nine months ended December 31, 2022. We are enclosing herewith: a) The Unaudited (Standalone & Consolidated) Financial Results of the Company for quarter and nine months ended on December 31, 2022; b) Limited Review Reports of the Statutory Auditors on the Standalone and Consolidated Financial Results of the Company for quarter and nine months ended on December 31, 2022 Dhampur Bio Organics Ltd - 543593 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to the provisions of Regulation 47 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, we enclose herewith the copies of Business Standard (English and Hindi both) dated January 24, 2023 wherein the Unaudited Financial Results of the Company for the Quarter and Nine Months ended December 31, 2022 have been published. Dhampur Bio Organics Ltd - 543593 - Announcement under Regulation 30 (LODR)-Investor Presentation
Revised Investor Presentation for the quarter and nine months ended December 31, 2022
